Figure 6From: Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer NKX3.1 haploinsufficiency results in the loss of negative control over the TMPRSS2-ERG gene fusion. Back to article page